Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT04177329 Not yet recruiting - Clinical trials for Subarachnoid Hemorrhage

Impact of Cardiac Complications on Outcomes of Patients After Subarachnoid Hemorrhage

Start date: December 1, 2019
Phase:
Study type: Observational

Patients with subarachnoid haemorrhage frequently develop cardiac complications affecting their outcome

NCT ID: NCT04174989 Completed - Clinical trials for Acute Upper Gastrointestinal Hemorrhage

Clinical Investigation of Safety and Performance of a Medical Device (ClearPlasma) for the Treatment of Patients With Acute Upper Gastrointestinal Hemorrhage.

Start date: October 24, 2020
Phase: N/A
Study type: Interventional

Pre-market, multi-center, international, double-blind, randomized, controlled, prospective, first-in-human clinical investigation of a Class IIb Investigational Medical Device, in which Patients presenting with acute upper gastrointestinal hemorrhage (AUGIH) and due to undergo a plasma transfusion, will be randomized to receive a one-time infusion (up to 8 hours) of up to two 250 mL units of plasminogen-depleted plasma (PDP) or fresh-frozen plasma (FFP). In case of transfusions needing more than two units, the third unit and above will consist in regular plasma for both treatment groups. Patients will be continuously monitored for 8 hours following the transfusion, and will be assessed between 8-12 hours after plasma transfusion or the following morning (the earlier of the two options), between 24-48 hours after plasma transfusion or at discharge (the earlier of the two options) and after 30+/-3 days after transfusion.

NCT ID: NCT04172376 Not yet recruiting - Clinical trials for Basal Ganglia Hemorrhage

Stereotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation II

SOITBE II
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Spontaneous cerebral hemorrhage is one of the main causes of death and disability all over the world, accounting for 20%-30% of all cerebrovascular diseases. Minimally invasive surgery of cerebral hemorrhage, especially puncture aspiration, can improve early and long-term neurological recovery in patients with cerebral hemorrhage. Until now, no standardized practice for minimally invasive surgery of spontaneous cerebral hemorrhage has been established. Hematoma puncture and drainage based on CT scans without precise localization and personalized approach design, which may lead to poor efficacy and high risk of complications. The investigators' hospital has much experience in treating cerebral hemorrhage with stereotactic puncture and aspiration. So the investigators conduct a prospective multicenter randomized controlled clinical trial across the country to determine the therapeutic effects of puncture aspiration plus thrombolysis treatment for the perioperative and long-term recovery of patients with small hematoma in deep basal ganglia via computerized precision coordinates and personalized approach design.

NCT ID: NCT04170270 Not yet recruiting - Clinical trials for Bleeding Peptic Ulcer

Oral Omeprazole in Bleeding Peptic Ulcer

Start date: November 2019
Phase: Early Phase 1
Study type: Interventional

Find out if there is a significant difference between clinical outcome among the patients with bleeding peptic ulcer treated with oral omeprazole compared to those treated with intravenous omeprazole.

NCT ID: NCT04170231 Completed - Cancer Clinical Trials

Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses

Start date: November 18, 2019
Phase:
Study type: Observational

"Bleeding in Critically Ill Children with Underlying Oncologic Diagnoses ," will be a prospective observational cohort study looking at the epidemiology of bleeding in the pediatric ICU population at MSK.

NCT ID: NCT04167644 Completed - Hypertension Clinical Trials

Proper Timing of Control of Hypertension and Outcome in Acute Spontaneous Intracerebral Hemorrhage.

Start date: May 1, 2018
Phase:
Study type: Observational

The ideal management of blood pressure in BP after acute intracerebral haemorrhage is still debated and whether a higher intensive reduction of blood pressure after acute intracerebral haemorrhage may be better or not is still controversial. Conflicting results from different randomized trials in regards to the clinical guidelines for management of hypertension in people with acute intracerebral hemorrhage (ICH). These results indicate that the management of BP and the prognosis after acute spontaneous ICH are very complicated. Therefore, analysis based on actual blood pressure (BP) accomplished may be a more efficient method to assess the impact of BP management on outcome of ICH. In our research, blood pressure (BP) management and prognosis were studied in patients with acute intracerebral hemorrhage to decide the perfect time control BP to improve outcome.

NCT ID: NCT04162808 Active, not recruiting - Clinical trials for Acute Coronary Syndrome

Bleeding Risk Assessment System for Antithrombotic Therapy of ACS

Start date: January 4, 2018
Phase:
Study type: Observational [Patient Registry]

Antithrombotic therapy is the cornerstone of the management of patients with acute coronary syndrome (ACS), which result in lower risk of mortality and ischemic events. But, accompanied side effect of bleeding always causing worsens outcomes. Tools to evaluate risk/benefit ratio is useful in daily practice. The in-used scores, such as CRUSADE, are derived from retrospective studies, without all types of ACS and without long-term prediction. This project aims to establish a database of anti-thrombosis treatment and bleeding in five large centers in Beijing through the observational registry of ACS. With the database, establish a bleeding risk assessment system that can be used for all ACS patients and can predict the full course of antithrombotic treatment.

NCT ID: NCT04153253 Completed - Clinical trials for Diabetic Vitreous Hemorrhage

Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage

Start date: March 7, 2018
Phase: Phase 4
Study type: Interventional

Prospective study comparing efficacy and safety of intravitreal aflibercept injection and panretinal photocoagulation to early vitrectomy for patients with diabetic vitreous hemorrhage.

NCT ID: NCT04149925 Completed - Clinical trials for Intraoperative Staple Line Bleeding as Measured by the Provided Bleeding Severity Scale

Endostapler Hemostasis Study

Start date: October 22, 2019
Phase:
Study type: Observational [Patient Registry]

The goal of this prospective, multi-center, post-market study is to measure AEON™ Endostapler performance with the EASY/THICK MODE feature for laparoscopic bariatric surgery against the Echelon Flex™ Powered Stapler system from Ethicon. Stapler performance will be evaluated primarily by incidence and degree of staple line bleeding through a third-party blinded primary outcome evaluator. The study will include 60 total consecutive cases of individuals undergoing a planned laparoscopic sleeve gastrectomy (LSG). The LSG procedure will be performed according to institutional standard-of-care and all subjects will undergo standard preoperative evaluation as well as post-operative care. Relevant data will be collected using the Data Collection sheet which should be filled out following each procedure by a member of the surgical or nursing team.

NCT ID: NCT04149171 Completed - Hemorrhagic Shock Clinical Trials

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage

Start date: September 26, 2018
Phase: Phase 3
Study type: Interventional

Study Design: Single-center, not-randomized, open-label, two-arms controlled pilot clinical trial. Health Condition: Patients with severe trauma with a need for transfusion and categorized as priority 0 or 1 according to the Catalan Health Service (CatSalut) Polytrauma Code (PPT)